-
Omicron wave disrupts wage growth hopes in Australia – leading macroeconomic influencers
Pharmaceutical-Technology
January 11, 2022
Some economists believe that the Omicron wave will be a clear risk to pay rises this year, as increasing case numbers threaten to disrupt Australia’s economic recovery.
-
FDA reduces time for Moderna Covid-19 vaccine booster to five months
Pharmaceutical-Technology
January 11, 2022
Common booster shot side effects include injection area pain, redness and swelling and fatigue.
-
Over 1.21b in China fully vaccinated against COVID-19
NMPA/Xinhua
January 11, 2022
Over 1.21 billion people in China have been fully vaccinated against COVID-19, a Chinese health official said at a press conference on Jan 8.
-
Clarivate Identifies Seven Potential Blockbuster Drugs in Annual Drugs to Watch Report
prnasia
January 10, 2022
Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of its annual Drugs to Watch™ report...
-
Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months
prnewswire
January 10, 2022
Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Moderna COVID-19 Vaccine to shorten the time between the completion of a primary series of the vaccine...
-
People may need another COVID-19 vaccine booster shot in fall of 2022: Moderna CEO
ExpressPharma
January 10, 2022
The efficacy of boosters against COVID-19 is likely to decline over the next few months, and people may need another shot in the fall of 2022, Stephane Bancel...
-
Chinese mainland reports 116 locally transmitted COVID-19 cases
NMPA/Xinhua
January 10, 2022
The Chinese mainland on Thursday reported 116 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Jan 7.
-
India to become hub for COVID-19 antiviral generic drugs: Fitch
ExpressPharma
January 10, 2022
India will become the largest global hub for COVID-19 antiviral general drug production after the drug controller granted Emergency Use Authorisation (EUA) to several pharmaceutical companies in the country to manufacture...
-
COVID-19 - Omicron: resistant to most monoclonal antibodies but neutralized by a booster dose
WorldPharmaNews
January 10, 2022
The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries. It is expected to become the dominant variant within a few weeks or months.
-
Do Not Use At-Home COVID Test Swabs in the Throat: FDA
drugs
January 10, 2022
Swabs that come with at-home rapid antigen COVID-19 tests should be used in the nose and not the throat, the U.S. Food and Drug Administration warns.